<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="52017" end="52022" sStart="51887" offset="130" sid="r7.1.use.v.0860" wn="1" wnkey="use%2:34:01::" annotator="cgozo" text="TBP was detected using monoclonal antibodies 3G3 and 2C1 [ [ 66 67 68 ] ]. TAF II 135 was detected using monoclonal antibody 20TA [ 5] which recognizes an epitope in the conserved C-terminal domain and monoclonal antibody 32TA raised against peptide P1 in the N-terminal region as described in [ 5]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="35697" end="35707" sStart="null" offset="94" sid="null" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="The onset of RAR?2 degradation coincides with that of TBP and TAF II 135 suggesting that these events are causaly related." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="35697" end="35707" sStart="null" offset="94" sid="null" wn="3" wnkey="suggest%2:32:02::" annotator="jeneale" text="The onset of RAR?2 degradation coincides with that of TBP and TAF II 135 suggesting that these events are causaly related." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="35697" end="35707" sStart="null" offset="94" sid="null" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="The onset of RAR?2 degradation coincides with that of TBP and TAF II 135 suggesting that these events are causaly related." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="13183" end="13191" sStart="null" offset="5" sid="r8.suggest.v.0752" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="This suggests that disappearance of TBP and TAF II 135 in extracts from differentiated cells does not occur at the transcriptional level, but rather results from a post-transcriptional event." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="4580" end="4589" sStart="null" offset="25" sid="r8.suggest.v.0440" wn="1" wnkey="suggest%2:32:00::" annotator="cgozo" text="It has also been suggested that targeted proteolysis is a means of regulating other physiological responses, such as signaling through STAT factors [ 45] and heat shock [ 46]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="35697" end="35707" sStart="null" offset="94" sid="null" wn="3" wnkey="suggest%2:32:02::" annotator="brubin" text="The onset of RAR?2 degradation coincides with that of TBP and TAF II 135 suggesting that these events are causaly related." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-4.anc" start="45207" end="45211" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="carichter" text="This idea is supported by our present results since we &lt;b&gt;show&lt;/b&gt; that TAF II 135 overexpression impairs both RAR?2 degradation and primitive endoderm differentiation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-4.anc" start="27985" end="27990" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="Addition of bt 2 cAMP induced the &lt;b&gt;rapid&lt;/b&gt; appearance of rounded cells with typical parietal endoderm morphology for both the wild type cells and lines A and B (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-4.anc" start="27985" end="27990" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="tofox" text="Addition of bt 2 cAMP induced the &lt;b&gt;rapid&lt;/b&gt; appearance of rounded cells with typical parietal endoderm morphology for both the wild type cells and lines A and B (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="49056" end="49062" sStart="null" offset="45" sid="r8.number.n.0565" wn="1" wnkey="number%1:07:00::" annotator="veweser" text="In most experiments an appropriate number of 10 cm plates were seeded with 10 5cells and after 24 hours (day 0) T-RA was added and protein or RNA extracts were made from one plate of cells on each of the indicated days." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="29908" end="29914" sStart="null" offset="171" sid="r9.normal.j.0826" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="In contrast, all three fTAF II 135(805-1083) expressing cell lines and several control lines picked at the same time all showed a normal T-RA response with respect to growth inhibition, differentiated cell morphology, and targeted depletion of TAF II 135 and TBP (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="685" end="691" sStart="null" offset="28" sid="r8.live.v.0509" wn="5" wnkey="live%2:42:00::" annotator="veweser" text="TAF II function in living cells has been studied in yeast where the use of temperature sensitive (TS) mutants has shown that many TAF II s are required for transcription of the majority of yeast genes [ [ 13 14 15 16 17 ] ]. In contrast, TS lesions in TAF II 145, TAF II 150, and TAF II 90 have a less dramatic effect affecting the expression of only a specific subset of genes mainly involved in the cell cycle [ [ 18 19 ] ] (for reviews see [ 3, 20]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="39704" end="39709" sStart="null" offset="12" sid="r9.level.n.0185" wn="1" wnkey="level%1:07:00::" annotator="veweser" text="A decreased level of TBP in differentiated F9 cells has previously been noted [ 62, 63]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="17212" end="17217" sStart="null" offset="74" sid="r9.level.n.0400" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="Taken altogether, the above results show that the intracellular level of TBP and TAF II 135 and consequently TFIID is significantly reduced in differentiated cells through T-RA-induced proteolytic degradation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="7771" end="7777" sStart="null" offset="30" sid="r9.level.n.0352" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="No significant changes in the levels of TAF II 100, TAF II 55, TAF II 20, TAF II 30, and TAF II 18, or the largest subunit of RNA polymerase II were observed between 3 and 10 days of T-RA treatment (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="20135" end="20140" sStart="null" offset="15" sid="r9.level.n.0366" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="In line A, the level of the ectopically expressed protein is higher than that of the endogenous protein, while in line B both the exogenous and the endogenous proteins are expressed at similar levels." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="14347" end="14351" sStart="null" offset="111" sid="r9.late.j.0922" wn="1" wnkey="late%3:00:00::" annotator="anfahmy" text="In contrast, in the presence of the inhibitors both proteins were readily detected even at late times where they are normally not observed (lanes 1-5)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="3872" end="3880" sStart="null" offset="277" sid="r11.function.n.0352" wn="3" wnkey="function%1:04:00::" annotator="vebatchelder" text="There is a very tight relationship between the potency of activation domains and their stability [ [ 35 36 37 38 ] ]. Activation domains and sequences required for degradation overlap and mutations in the VP16 activation domain which impair its function result in enhanced protein stability [ 35]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="12558" end="12562" sStart="null" offset="169" sid="r9.full.j.0093" wn="3" wnkey="full%5:00:00:complete:00" annotator="veweser" text="Thus, the selective depletion of TBP and TAF II 135 requires that the F9 cells respond, at least partially, to T-RA, but does not require full differentiation to take place." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="12558" end="12562" sStart="null" offset="169" sid="r9.full.j.0093" wn="3" wnkey="full%5:00:00:complete:00" annotator="cgozo" text="Thus, the selective depletion of TBP and TAF II 135 requires that the F9 cells respond, at least partially, to T-RA, but does not require full differentiation to take place." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="12558" end="12562" sStart="null" offset="169" sid="r9.full.j.0093" wn="2" wnkey="full%5:00:01:whole:00" annotator="brubin" text="Thus, the selective depletion of TBP and TAF II 135 requires that the F9 cells respond, at least partially, to T-RA, but does not require full differentiation to take place." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="12558" end="12562" sStart="null" offset="169" sid="r9.full.j.0093" wn="2" wnkey="full%5:00:01:whole:00" annotator="anfahmy" text="Thus, the selective depletion of TBP and TAF II 135 requires that the F9 cells respond, at least partially, to T-RA, but does not require full differentiation to take place." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="20668" end="20672" sStart="null" offset="113" sid="r9.fold.v.0829" wn="2147483645" wnkey="null" annotator="veweser" text="Both of the cell lines expressing fTAF II 135(372-1083) showed an approximately 2-fold accelerated growth rate compared to wild type cells while no significant increase was seen in the fTAF II 135(805-1083) expressing cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="15838" end="15842" sStart="null" offset="306" sid="r9.fold.v.0984" wn="2147483645" wnkey="null" annotator="brubin" text="Comparison of the TBP and TAF II 135 levels in extracts from day 7 differentiated cells prepared in the presence of MG132 showed that they were indeed significantly reduced compared to undifferentiated cells or day 3 differentiated cells (approximately 3 fold, Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="9582" end="9586" sStart="null" offset="56" sid="r9.fold.v.0336" wn="2147483645" wnkey="null" annotator="brubin" text="Similarly, TBP was readily detected in the 20-fold dilution of F9 cell extract, while the levels detected in the differentiated cell extracts were significantly lower (compare lanes 5 and 6)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="2907" end="2911" sStart="null" offset="328" sid="r9.fold.v.0286" wn="" wnkey="null" annotator="anfahmy" text="TAF II 135 also contains two conserved regions, CR-I and CR-II, which are shared with the Drosophila homologue dTAF II 110 and mammalian TAF II 105 [ 27, 30] The CR-II region is also shared with the yeast homologue yTAF II 48 [ 31, 32] and contains a histone fold domain required for heterodimerisation with hTAF II 20/yTAF II 68 [ 33, 34]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="28549" end="28558" sStart="null" offset="55" sid="r8.1.different.j.0199" wn="2" wnkey="different%5:00:00:other:00" annotator="brubin" text="The morphology of these cells was completely different from those of undifferentiated or primitive endoderm cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="30370" end="30375" sStart="null" offset="136" sid="r8.ask.v.0139" wn="4" wnkey="ask%2:32:04::" annotator="brubin" text="To determine whether the down regulation of TBP and TAF II 135 is specific to F9 cell differentiation we asked whether this phenomenon could be observed in an unrelated cell type." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-4.anc" start="27879" end="27884" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" annotator="cgozo" text="After 6 days of T-RA treatment, bt 2 cAMP was &lt;b&gt;added&lt;/b&gt; to induce parietal endoderm differentiation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="24679" end="24686" sStart="null" offset="106" sid="r11.absence.n.0904" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="In wild-type cells, the proportion of early apoptotic cells increased from 13% in the absence of T-RA to 26% after 5 days of T-RA treatment (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="16057" end="16064" sStart="null" offset="95" sid="r11.absence.n.0857" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="Nevertheless, these proteins do not disappear completely as they do in the absence of MG132 (lanes 2-3)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="16165" end="16172" sStart="null" offset="78" sid="r11.absence.n.0243" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="Therefore, the complete disappearance of these proteins seen in the absence of protease inhibitors indicates that there is further degradation in the extracts which exaggerates the differences between differentiated and undifferentiated cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="35208" end="35212" sStart="null" offset="56" sid="r11.able.j.0976" wn="1" wnkey="able%3:00:00::" annotator="vebatchelder" text="In this respect we note that we have not been able to recover F9 cell lines significantly overexpressing TBP suggesting that TBP overexpression is toxic." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-4.anc" start="47119" end="47123" sStart="null" offset="84" sid="r11.able.j.0562" wn="1" wnkey="able%3:00:00::" annotator="vebatchelder" text="Investigation of this has been hampered by the fact that we have not been able to isolate F9 cell lines stabley expressing full length TAF II 135." />
  </sentences>
</list>